• BIOHEALTH CAPITAL REGION
  • GREATER PHILADELPHIA
  • NORTH CAROLINA
  • MEDIA
    • News + Articles
      • People
      • Real Estate
      • Funding
      • Industry Trends
      • Career & Professional Development
    • Events
      • Events Calendar
      • Submit an Event [for FREE]
  • COMMUNITY
    • Grow Your Professional Network
    • BioHealth Capital Region (MD/DC/VA)
    • Greater Philadelphia (PA/DE/NJ)
    • North Carolina (NC)
  • JOBS
    • Get Hired
    • Jobs
    • Career Resources
  • FOR EMPLOYERS
    • Hire An Expert
    • Services
GET HIRED
HIRE

SERB Pharma Inks Licensing Deal with SFJ for Brilinta Reversal Agent

Published on : May 12, 2023May 12, 2023 Published by : Mark Terry

SERB Pharma Inks Licensing Deal with SFJ for Brilinta Reversal Agent By Mark TerryMay 12, 2023 Philadelphia-based SERB Pharmaceuticals has inked a licensing deal with San Francisco’s SFJ Pharmaceuticals for [….]

Tagged in : AstraZeneca Brilinta BTG Pharmaceuticals Philadelphia SERB Pharma SFJ Pharmaceuticals
Categorized in : Newsletter Philadelphia News

LATEST POSTS

  • BioFactura Receives $7.8 Million in Funding for Contract Options for its SmallpoxBiodefense Therapeutic
  • PumasAI is Set to Revolutionize Pharmacometrics and Clinical Pharmacology with the Launch of AskPumas and DeepPumas
  • In Conversation with John Swartley, Chief Innovation Officer, University of Pennsylvania
  • People on the Move: Dr. Janet Woodcock Joins Every Cure Board of Directors
  • Legend Biotech Chooses Philadelphia for New R&D Center

About BioBuzz

Our History

Our Expert Advisors

Our Board of Buzz

Our Ambassadors

  • Online Community
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube

Terms & Conditions  Privacy Policy
Made with ♥ in Baltimore

© 2023 BioBuzz Media™

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy